Novartis announces results from CLARITY study
Novartis new data reinforces superiority of Cosentyx versus Stelara in achieving skin clearance for psoriasis patients
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
PMB growing in Japan and Israel
Mergermarket, an Acuris company, has released full year 2017 Pharma, Medical & Biotech (PMB) report
Dr Reddy’s Q2 Revenues at Rs 35.5 Bn
H1 Revenues at Rs 68.6 Bn, Q2 EBITDA at Rs 6.9 Bn
Sanofi, Regeneron accelerate investment for clinical development
The companies collaborate for the clinical development of PD-1 antibody cemiplimab in oncology and dupilumab in Type 2 allergic…
Lynparza approved by US FDA
Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer
Lupin forays into OTC segment
Launches Softovac under the umbrella of Lupin Life Consumer Healthcare
Glenmark initiates Phase IIb dose range finding study
The study will evaluate safety and efficacy of GRC 27864 in patients with moderate osteoarthritic pain
Intas acquires generics business of Actavis in UK, Ireland
This acquisition is set to more than double Intas' pan-European operations, with pro-forma revenues exceeding $500 million
Livongo and Lilly collaborate on real-world diabetes research
Companies join forces to advance predictive and prescriptive recommendations for people with diabetes
Eisai set-ups new OSD production facility in China
Operations are expected to commence in the second half of fiscal 2018
EU approves AstraZeneca’s Fasenra
Fasenra is comapany's first respiratory biologic medicine for severe eosinophilic asthma
Biogen and Eisai promote multiple sclerosis treatments in Japan
Based on the agreement two companies will jointly conduct promotional activities at the clinical facilities
Novartis appoints Elizabeth Barrett as oncology head
Barrett currently is Global President Oncology at Pfizer
Ministry of AYUSH welcomes Traditional Systems of Medicine and Homeopathy initiatives from Malaysia
5th Bilateral Meeting was presided by Pramod Kumar Pathak, Joint Secretary, Ministry of AYUSH from Indian side and Deputy Director…
Hetero launches ‘Mabura’ in India
Mabura is the Biosimilar version of AbbVie’s Humira
Hilleman Laboratories partners with Future Vaccine Manufacturing Hub
Hilleman Laboratories to collaborate with Imperial College, London and other premier international bodies to manufacture low-cost…
11th Annual Conference of ISCR will be held in Bengaluru
The two-day event from January 19 to 20, will bring together different stakeholders across the clinical research continuum on a…